Steve Lo

Track

Insider profile

Currently holds a position at Zosano Pharma Corp

Performance

Overall performance
1.5
Performance over holding periods
1.5
30 days 90 days 120 days
Average return 25% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Executive Officer, Director Zosano Pharma Corp Oct. 21, 2019 -
Chief Commercial Officer Puma Biotechnology Inc Sept. 1, 2015 - Oct. 18, 2019
Senior Vice President, Oncology Corcept Therapeutics Inc Feb. 1, 2015 - Sept. 4, 2015
Senior Vice President, Chief Commercial Officer Corcept Therapeutics Inc Nov. 19, 2013 - Feb. 1, 2015
Vice President - Commercial Operations Corcept Therapeutics Inc Sept. 16, 2010 - Nov. 19, 2013
Steve Lo's trades of Vaxart Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Vaxart Inc (VXRT)
Transaction date
Purchase
Price
67.11
Quantity 80,290 +5.8%
Value US$3,034,262
Transaction date
Sale
Price
432.88
Quantity 60,795 -26.6%
Value US$3,915,891
Transaction date
Sale
Price
328.97
Quantity 67,129 +10.0%
Value US$2,002,785
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-05-19 2025-05-19
US Vaxart Inc (VXRT)
B Purchase
80,290 +5.8%
67.11
US$3,034,262 		80,290 +5.8% 67.11 US$3,034,262
2022-06-07 2022-06-06
S Sale
60,795 -26.6%
432.88
US$3,915,891 		60,795 -26.6% 432.88 US$3,915,891
2022-04-01 2022-03-31
S Sale
67,129 +10.0%
328.97
US$2,002,785 		67,129 +10.0% 328.97 US$2,002,785
2019-07-24 2019-07-22
PlS Planned sale
1,852 -8.7%
10.04
US$18,600 		1,852 -8.7% 10.04 US$18,600
2019-01-24 2019-01-22
PlS Planned sale
2,114 -9.0%
24.91
US$52,664 		2,114 -9.0% 24.91 US$52,664
2018-07-24 2018-07-20
PlS Planned sale
1,839 -7.3%
51.85
US$95,360 		1,839 -7.3% 51.85 US$95,360
2018-01-24 2018-01-22
PlS Planned sale
1,858 -6.8%
92.85
US$172,515 		1,858 -6.8% 92.85 US$172,515
2017-07-24 2017-07-20
PlS Planned sale
1,990 -6.8%
94.90
US$188,853 		1,990 -6.8% 94.90 US$188,853
2017-01-24 2017-01-20
PlS Planned sale
2,290 -7.3%
33.24
US$76,108 		2,290 -7.3% 33.24 US$76,108